VANCOUVER, British Columbia, April 17, 2025 Zymeworks Inc. (Nasdaq: ZYME), a prominent player in the biotechnology sector currently in its clinical stage, is set to unveil its financial performance for the first quarter of 2025. This announcement is scheduled for May 8, 2025, following the market's close. In conjunction with the financial report, Zymeworks will conduct a conference call and webcast aimed at discussing these results and offering a corporate update. The call is expected to commence at 4:30 PM Eastern Time on the same day.

Interested parties can access the live event via the internet, and details for dial-in will be provided, along with replays available on Zymeworks official site at